Pleasanton, CA, United States of America

Ashok Bhandari

This inventor holds 31 USPTO granted patents and 35 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Peptide Therapeutics. Top assignees: Protagonist Therapeutics, Inc., Janssen Biotech, Inc., Affymax, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ashok Bhandari. Retrieved from https://idiyas.com/inventor/ashok-bhandari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 35)

% Patents Active = 90.3

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 7 (Patent Applications = 28)

Average Co-Inventor Count = 5.4

ph-index = 13

Forward Citations = 333(Granted Patents)

Location History:

Cupertino, CA (US) (2012)
Pleasanton, CA (US) (2016 - 2024)
Newark, CA (US) (2023 - 2024)

Company Filing History:

29 out of 35

Protagonist Therapeutics, Inc.

patents

3 out of 433

Janssen Biotech, Inc.

Janssen Pharmaceutica Nv

patents

5. 1 out of 1

Protaganist Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Peptide Inhibitors

Interleukin-23

Inflammatory Diseases

Hepcidin Mimetics

Integrin Antagonists

Cyclic Peptides

Opioid Agonists

Thioether Antagonists

Monomer-Dimer Antagonists

Oral Peptide Inhibitors

Nitrogen-Based Linkers

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673974 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2026-07-07),

2. 12655185 - PEPTIDE INHIBITORS OF INTERLEUKIN-23 AND THEIR USE TO TREAT INFLAMMATORY DISEASES (2026-06-16),

3. 12552836 - PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES (2026-02-17),

4. 12478617 - Lipidated peptide inhibitors of interleukin-23 receptor (2025-11-25),

5. 12234300 - Conjugated hepcidin mimetics (2025-02-25),

6. 12018057 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2024-06-25),

7. 11939361 - Compositions of peptide inhibitors of Interleukin-23 receptor (2024-03-26),

8. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2024-01-30),

9. 11845808 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2023-12-19),

10. 11840581 - α4β7 thioether peptide dimer antagonists (2023-12-12),

11. 11753443 - Conjugated hepcidin mimetics (2023-09-12),

12. 11472842 - Analogues of hepcidin mimetics with improved in vivo half lives (2022-10-18),

13. 11111272 - α4α7 peptide monomer and dimer antagonists (2021-09-07),

14. 11041000 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2021-06-22),

15. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2021-03-09),

Title: Innovations and Contributions of Ashok Bhandari: A Pioneer in Pharmaceutical Patents

Introduction: Ashok Bhandari, based in Pleasanton, CA, is a prominent inventor recognized for his significant contributions to the field of pharmaceuticals, holding an impressive total of 27 patents. His innovative work focuses on developing strategies to improve therapeutic effectiveness, particularly in treating inflammatory diseases.

Latest Patents: Among Ashok Bhandari's most notable inventions are his latest patents, which include:

1. **Conjugated Hepcidin Mimetics** - This invention provides hepcidin analogues with improved in vivo half-lives, along with related pharmaceutical compositions and methods for their use.

2. **Peptide Inhibitors of Interleukin-23 Receptor** - This patent introduces novel peptide inhibitors targeting the interleukin-23 receptor, which may aid in the treatment or prevention of various diseases and disorders, including inflammatory bowel diseases.

Career Highlights: Throughout his career, Ashok has made impactful advancements while working at notable organizations such as Protagonist Therapeutics, Inc. and Janssen Biotech, Inc. His work at these companies has led to pivotal developments in therapeutic inventions, allowing for better clinical outcomes in patients.

Collaborations: Ashok has collaborated with esteemed professionals in the field, including Brian Troy Frederick and Dinesh Vinoobhai Patel. These collaborations have fostered a rich environment for innovation and discovery, critical for advancing healthcare solutions.

Conclusion: Ashok Bhandari stands out as a key figure in the pharmaceutical industry, with his remarkable inventions and patents focusing on critical therapeutic areas. His dedication to innovation and collaboration continues to influence advancements in treating inflammatory conditions, paving the way for future breakthroughs in medicine.

Profile summary based on public USPTO records.